Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nanovibronix Inc (NAOV)

Nanovibronix Inc (NAOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nanovibronix Inc 969 PRUITT AVE TYLER TX 77569 USA

www.nanovibronix.com Employees: 16 P: 914-233-3004 F: 914-376-6111

Description:

NanoVibronix, Inc. is a medical device company. The Company's products include WoundShield(TM), a patch-based therapeutic ultrasound device which facilitates tissue regeneration and wound healing; PainShield(R), a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures; UroShield(TM), an ultrasound-based product which is designed to prevent biofilm in urinary catheters; NanoVibronix, lightweight pump which allow contamination-free handling of infected wound exudate and enhanced patient mobility. NanoVibronix, Inc. is based in Melville, New York.

Key Statistics

Overview:

Market Capitalization, $K 2,650
Enterprise Value, $K -630
Shares Outstanding, K 3,752
Annual Sales, $ 2,280 K
Annual Net Income, $ -3,710 K
Last Quarter Sales, $ 380 K
Last Quarter Net Income, $ -1,000 K
EBIT, $ -2,910 K
EBITDA, $ -2,910 K
60-Month Beta 1.51
% of Insider Shareholders 4.24%
% of Institutional Shareholders 16.39%
Float, K 3,593
% Float 95.76%
Short Volume Ratio 0.13

Growth:

1-Year Return -48.08%
3-Year Return -97.01%
5-Year Return -98.76%
5-Year Revenue Growth 612.50%
5-Year Earnings Growth 83.44%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.36 on 11/14/24
Next Earnings Date 11/18/24
Earnings Per Share ttm -1.23
EPS Growth vs. Prev Qtr -44.00%
EPS Growth vs. Prev Year 14.29%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 02/09/23

NAOV Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -101.17%
Return-on-Assets % -53.03%
Profit Margin % -162.72%
Debt/Equity 0.00
Price/Sales 1.07
Price/Cash Flow N/A
Price/Book 0.97
Book Value/Share 0.67
Interest Coverage -13.72
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar